Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
CNS Oncology
|
November 27, 2019
Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastoma
Igor Makhlin, Ryan D Salinas, Daniel Zhang, et al.
Neuro-Oncology Advances
|
February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma
Stephen J Bagley, Jacob Till, Aseel Abdalla, et al.
Plos One
|
March 31, 2016
Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
Zev A Binder, Kelli M Wilson, Vafi Salmasi, et al.
Cell Stem Cell
|
December 10, 2024
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
Meghan Logun, Xin Wang, Yusha Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 1, 2024
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma
Nannan Li, Jesse L Rodriguez, Yibo Yin, et al.
Stem Cell Reports
|
June 20, 2025
Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture model
Yusha Sun, Xin Wang, Zhijian Zhang, et al.
Neuro-Oncology Advances
|
March 7, 2020
Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
Seyed Ali Nabavizadeh, Jeffrey B Ware, Samantha Guiry, et al.
Plos One
|
October 23, 2013
Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome
Zev A Binder, I-Mei Siu, Charles G Eberhart, et al.
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Cancer Immunology Research
|
April 30, 2014
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches
Gilson S Baia, Otavia L Caballero, Janelle S Y Ho, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
CNS Oncology
|
November 27, 2019
Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastoma
Igor Makhlin, Ryan D Salinas, Daniel Zhang, et al.
Neuro-Oncology Advances
|
February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma
Stephen J Bagley, Jacob Till, Aseel Abdalla, et al.
Plos One
|
March 31, 2016
Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
Zev A Binder, Kelli M Wilson, Vafi Salmasi, et al.
Cell Stem Cell
|
December 10, 2024
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
Meghan Logun, Xin Wang, Yusha Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 1, 2024
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma
Nannan Li, Jesse L Rodriguez, Yibo Yin, et al.
Stem Cell Reports
|
June 20, 2025
Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture model
Yusha Sun, Xin Wang, Zhijian Zhang, et al.
Neuro-Oncology Advances
|
March 7, 2020
Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
Seyed Ali Nabavizadeh, Jeffrey B Ware, Samantha Guiry, et al.
Plos One
|
October 23, 2013
Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome
Zev A Binder, I-Mei Siu, Charles G Eberhart, et al.
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Cancer Immunology Research
|
April 30, 2014
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches
Gilson S Baia, Otavia L Caballero, Janelle S Y Ho, et al.
Page
of 7